Indefinite Delivery Contract SPE2DR25D9306
Award Date 11/13/25
Last Date to Order 12/31/26
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV award SPE2DR25D9957 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, was awarded by the Defense Logistics Agency (DLA) and is valid through December 2026. The purpose of this IDC is to enable DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DR25D9246 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
- The federal contract IDV award SPE2DX16D9902 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which runs through November 2026, covers a diverse portfolio of branded and...
- The Indefinite Delivery Contract SPE2DR25D9263 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at up to $4,999,999 and has an ultimate completion date of December 31, 2036. Under this single-award IDC, DMS Pharmaceutical Group Inc. will provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare...
- The federal contract IDV award SPE2DX15D9647 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables,...
- The federal contract IDV awarded to DMS Pharmaceutical Group Inc. is a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an extensive portfolio of pharmaceutical...
- The federal contract IDV award SPE2DX16D9930 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.99, was awarded by the Defense Logistics Agency (DLA) and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
- The federal contract IDV SPE2DR25D9903 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The single-award Indefinite Delivery Contract (IDC), valued at $499,999,999 and valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC...
- The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DX program, has an ultimate completion date of November 30, 2024 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...